Form 4: Major Shareholder BP4 S.r.l. Reduces Stake in Milestone Scientific Amidst Declining Share Price

BP4 S.r.l., a 10% owner and director of Milestone Scientific Inc., reported multiple sales of common stock totaling 27,882 shares between June 23 and June 30, 2025, reducing its beneficial ownership to 9,417,608 shares.

Summary

• BP4 S.r.l., identified as a Director and 10% Owner of Milestone Scientific Inc. (MLSS), filed a Form 4.
• The filing reports a series of direct sales of Common Stock, Par Value $0.001, between June 23, 2025, and June 30, 2025.
• A total of 27,882 shares were disposed of across five separate transactions.
• The sale prices ranged from $0.8604 per share on June 23, 2025, down to $0.65 per share on June 30, 2025.
• Following these transactions, BP4 S.r.l.'s direct beneficial ownership decreased from 9,439,557 shares to 9,417,608 shares.

Sentiment

Score: 3

Explanation: Insider selling, particularly by a large shareholder and director, is generally viewed negatively by the market as it can signal a lack of confidence or a belief that the stock is overvalued. The declining sale prices further reinforce a negative sentiment.

Negatives

• A significant insider, BP4 S.r.l., which holds a 10% ownership stake and has a director relationship with Milestone Scientific Inc., has reduced its holdings.
• The sales occurred over several days, indicating a sustained reduction in the insider's position.
• The average sale price declined over the period of transactions, from $0.8604 to $0.65, suggesting sales into a falling market or a willingness to sell at lower prices.

Risks

• Insider selling by a 10% owner and director may signal a lack of confidence in the company's near-term prospects or valuation by a key stakeholder.
• Sustained selling pressure from a large shareholder could negatively impact the stock price due to increased supply and potential investor concern.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders may interpret the insider selling as a negative signal, potentially leading to decreased investor confidence and downward pressure on the stock price.

Key Dates

Recommendation

Keywords

Milestone Scientific Inc., MLSS, SEC Form 4, insider trading, beneficial ownership, stock sales, BP4 S.r.l., director, 10% owner, equity transactions